Trial Profile
Effects of an Opiod Sparing Care Pathway for Patients undergoing Obesity Surgery
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2024
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Esketamine (Primary) ; Lidocaine (Primary) ; Desflurane; Oxycodone; Propofol; Remifentanil
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms OS-PCC
- 31 Aug 2023 Planned End Date changed from 31 Dec 2025 to 31 Dec 2027.
- 31 Aug 2023 Planned primary completion date changed from 31 Dec 2023 to 31 Jan 2024.
- 15 Mar 2022 Planned End Date changed from 31 Dec 2024 to 31 Dec 2025.